-
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 20 Jan 2025 02:41:17 America/New_York
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat January 20, 2025 Share Link copied to clipboard. Shares of Enanta Pharmaceuticals, Inc.
Read more...